S. Beauchemin

发表

Ethanol production from residual lignocellulosic fibers generated through the steam treatment of whole sorghum biomass.

J. Lavoie, I. Boboescu, Jérémie Damay, 2019, Bioresource technology.

Optimization of the potency and pharmacokinetic properties of a macrocyclic ghrelin receptor agonist (Part I): Development of ulimorelin (TZP-101) from hit to clinic.

Martin Brassard, D. Veber, S. Beauchemin, 2011, Journal of medicinal chemistry.

Single-stage extraction of whole sorghum extractives and hemicelluloses followed by their conversion to ethanol

J. Lavoie, I. Boboescu, Jérémie Damay, 2019, Industrial Crops and Products.

Novel Insights into Structure–Activity Relationships of N‐Terminally Modified PACE4 Inhibitors

S. Beauchemin, R. Day, A. Kwiatkowska, 2016, ChemMedChem.

Exploration of the fifth position of leu‐enkephalin and its role in binding and activating delta (DOP) and mu (MOP) opioid receptors

R. Leduc, S. Beauchemin, L. Gendron, 2019 .

Design, Synthesis, and Structure−Activity Relationship Studies of a Potent PACE4 Inhibitor

S. Beauchemin, R. Day, A. Kwiatkowska, 2014 .

Discovery of a new class of macrocyclic antagonists to the human motilin receptor.

S. Beauchemin, T. Peeters, M. Vezina, 2006, Journal of medicinal chemistry.

Optimization of furin inhibitors to protect against the activation of influenza hemagglutinin H5 and Shiga toxin.

S. Beauchemin, R. Day, F. Malouin, 2014, Journal of medicinal chemistry.

Efficient parallel synthesis of macrocyclic peptidomimetics.

Daniel Fortin, Martin Brassard, Ruoxi Lan, 2008, Bioorganic & medicinal chemistry letters.

On the mechanism of alcoholysis of allylic and benzylic alcohols and of epoxides in the presence of ceric ammonium nitrate

S. Beauchemin, B. Daoust, J. Lessard, 1996 .

Design, Synthesis, and Structure−Activity Relationship Studies of a Potent PACE4 Inhibitor

S. Beauchemin, R. Day, A. Kwiatkowska, 2014 .